Warberg Asset Management »

Cellectar Biosciences shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $41k 14k 2.95

More positions owned by Warberg Asset Management

Spdr S&p 500 Etf Tr Put Put Option
Axon Enterprise Note 0.500%12/1 (Principal)
Invesco Qqq Tr Put Put Option
Western Digital Corp Note 3.000%11/1 (Principal)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Box Note 1/1 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Post Hldgs Note 2.500% 8/1 (Principal)
Lumentum Hldgs Note 0.500%12/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)

View all positions for Warberg Asset Management

Top funds holding Cellectar Biosciences

Bleichroeder
Vanguard Group
DRW Holdings
Geode Capital Management
Sequoia Financial Advisors
Warberg Asset Management
XTX Topco
Susquehanna International
Riverview Capital Advisers
BlackRock
UBS Group
Tower Research Capital
TD Waterhouse Canada
SBI Securities
Advisor Group Holdings

View all funds holding Cellectar Biosciences